HLA-E expression levels, typically elevated in tumor cells compared to healthy tissues, lead to the inhibition of cytotoxic NK cells and CD8 T lymphocytes through interaction with the NKG2A/CD94 heterodimer (2, 21, 31, 32). The gene discussed is KLRC1; the disease is neoplasm.